Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Nonbullous impetigo is the most common bacterial skin infection in children, often needing treatment to prevent complications.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

A woman with lupus and severe nerve damage improved with specific treatments.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Poor body image from pain can lead to more depression in lupus patients.

Higher inflammation markers are linked to more severe alopecia areata.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Children's hair diseases include compulsive hair-pulling, easily plucked hair, scalp fungal infections, and head lice, each requiring specific diagnosis and treatment.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

PCOD causes hormonal imbalances and infertility, requiring early diagnosis and treatment.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Treating gum disease and stress may help improve alopecia.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Higher leptin levels link to hair loss.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Regular eye exams are important for detecting serious complications in lupus patients.

Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.

People with alopecia areata have more inflammation but similar heart risk as healthy people.